Skip to main content
Log in

Cancer médullaire de la thyroïde familial isolé

Familial medullary thyroid carcinoma: case report

  • Cas Clinique / Case Report
  • Published:
Oncologie

Abstract

The authors describe the cases of two patients from the same family who presented medullary thyroid carcinoma (MTC). Hormone measurement showed a significantly elevated basal calcitonin. The treatment was total thyroidectomy. Histological findings showed multifocal, bilateral MTC. Direct sequencing identified in both patients a heterozygous germline missense mutation TGC-TTC at codon 634 of exon 11 in the RET gene that causes an animosubstitution of cysteine to phenylalanine. The clinical outcome of the cases is considered to be favourable.

Résumé

Les auteurs rapportent deux cas de carcinome médullaire de la thyroïde (CMT) appartenant à la même famille. Le dosage hormonal a montré une élévation significative de la calcitonine. Le traitement consistait en une thyroïdectomie totale. L’examen anatomopathologique a mis en évidence un CMT bilatéral et plurifocal. Le séquençage direct du proto-oncogène RET a permis d’identifier, chez les deux patientes, une mutation germinale spécifique TGC-TTC, sous forme hétérozygote, au niveau du codon 634 de l’exon 11 à l’origine de la substitution de l’acide aminé cystéine en phénylalanine. L’évolution clinique semble être favorable, mais sans confirmation biologique de la guérison.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Références

  1. Ainahi A, Kebbou M, Timinouni M, et al. (2006) Study of the RET gene and its implication in thyroid cancer: Morocco case family. Indian J Cancer 43: 122–126

    Article  CAS  PubMed  Google Scholar 

  2. Asai N, Iwashita T, Matsuyama M, et al. (1995) Mechanism of activation of the RET proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15: 1613–1619

    CAS  PubMed  Google Scholar 

  3. Benazzouz B, Chraibi A, Doghmi Y, et al. (2006) Characterization of RET proto-oncogene C634Y mutation in a Moroccan family with multiple endocrine neoplasia type 2A. Ann Endocrinol 67: 21–26

    CAS  Google Scholar 

  4. Berndt I, Reuter M, Saller B, et al. (1998) A new hot spot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83: 770–774

    Article  CAS  PubMed  Google Scholar 

  5. Donis-Keller H, Dou S, Chi D, et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851–856

    Article  CAS  PubMed  Google Scholar 

  6. Dralle H, Gimm O, Simon D, et al. (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22: 744–750

    Article  CAS  PubMed  Google Scholar 

  7. Eng C, Clayton D, Schuffenecker I, et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276: 1575–1579

    Article  CAS  PubMed  Google Scholar 

  8. Frank-Raue K, Hoppner W, Frilling A, et al. (1996) Mutations of RET proto-oncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. J Clin Endocrinol Metab 81: 1780–1783

    Article  CAS  PubMed  Google Scholar 

  9. Huang SC, Koch CA, Vortmeyer AO, et al. (2000) Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res 60: 6223–6226

    CAS  PubMed  Google Scholar 

  10. Mulligan LM, Marsh DJ, Robinson BG, et al. (1995) Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 238: 343–346

    Article  CAS  PubMed  Google Scholar 

  11. Niccoli-Sire P, Murat A, Baudin E, et al. (1999) Early or prophylactic thyroidectomy in MEN2/FMTC gene carriers: results in 71 thyroidectomized patients. Eur J End 141: 468–474

    Article  CAS  Google Scholar 

  12. Punales MK, Graf H, Gross JL, et al. (2003) RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. J Clin Endocrinol Metab 88:2644–2649

    Article  CAS  PubMed  Google Scholar 

  13. Robledo M, Gil L, Pollan M, et al. (2003) Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Res 63: 1814–1817

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Ainahi.

About this article

Cite this article

Ainahi, A., Kebbou, M., Timinouni, M. et al. Cancer médullaire de la thyroïde familial isolé. Oncologie 12 (Suppl 1), 18–20 (2010). https://doi.org/10.1007/s10269-008-0862-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-008-0862-y

Keywords

Mots clés

Navigation